Biotech Stocks
| 1 |  ALNYALNYLAM PHARMACEUTICALS, INC. | — | $164.54+5.04% | 90.9Bullish | +1.2% | $543.13K | Cluster | Nov 10, 2026 | $22.04B | Pharmaceutical Preparations | 8.3 | 0.03% of companyunchanged past 90 days | — | |
| 2 |  MDGLMADRIGAL PHARMACEUTICALS, INC. | — | $417.24-1.87% | 92.9Bullish | +11.5% | $35.02M | Big BuyRepeat | Nov 6, 2026 | $9.69B | Pharmaceutical Preparations | — | 0.92% of companydown from 0.98% in 90 days | — | |
| 3 |  STVNStevanato Group S.p.A. | — | $14.94+4.03% | 90.9Bullish | +7.5% | $601.15K | Cluster | Nov 9, 2026 | $4.08B | Surgical & Medical Instruments & Apparatus | 25.3 | 0.17% of companyup from 0.16% in 90 days | — | |
| 4 |  ENOVEnovis CORP | — | $28.29+2.35% | 97.5Bullish | +32.1% | $599.54K | CEO BuyClusterRepeat | Nov 11, 2026 | $1.63B | Orthopedic, Prosthetic & Surgical Appliances & Supplies | — | 0.68% of companyup from 0.63% in 90 days | — | |
| 5 |  ADRXADARx Pharmaceuticals, Inc. | — | $14.53-2.55% | 96.2Bullish | -12.3% | $87.75M | ClusterBig BuyRepeat | Sep 28, 2026 | $1.61B | Pharmaceutical Preparations | — | 28.5% of companyup from 26.0% in 90 days | — | |
| 6 |  INBXInhibrx Biosciences, Inc. | — | $83.18-5.20% | 97.7Bullish | -13.5% | $6.35M | CEO BuyClusterBig BuyRepeat | Oct 14, 2026 | $1.22B | Biological Products, (No Diagnostic Substances) | — | 9.6% of companyup from 9.2% in 90 days | — | |
| 7 |  BBTXBambusa Therapeutics, Inc. | — | $16.01-4.42% | 95.6Bullish | +5.8% | $58.64M | ClusterBig BuyRepeat | Nov 2, 2026 | $815.59M | Healthcare | — | 18.6% of companyup from 17.9% in 90 days | — | |
| 8 |  ETRAElectra Therapeutics, Inc. | — | $8.09-11.20% | 98.9Bullish | -29.0% | $48.70M | ClusterBig BuyRepeat | Nov 10, 2026 | $507.78M | Biological Products, (No Diagnostic Substances) | — | 24.8% of companyup from 15.8% in 90 days | — | |
| 9 |  AQSTAquestive Therapeutics, Inc. | — | $3.86+8.13% | 89.6Bullish | +0.8% | $99.33K | Repeat | Nov 10, 2026 | $485.14M | Pharmaceutical Preparations | — | 0.69% of companydown from 0.73% in 90 days | — | |
| 10 |  CYBNCYBIN INC. | — | $8.28+1.22% | 94.6Bullish | -32.5% | $9.67M | CEO BuyClusterBig BuyRepeat | Sep 29, 2026 | $413.02M | Pharmaceutical Preparations | — | 41.2% of companyup from 37.6% in 90 days | — | |
| 11 |  ASPEAspen Neuroscience, Inc. | — | $12.53-7.94% | 89.5Bullish | -9.3% | $68.00M | ClusterBig BuyRepeat | Nov 2, 2026 | $364.35M | Pharmaceutical Preparations | — | 12.3% of companyup from 8.9% in 90 days | — | |
| 12 |  VNDAVanda Pharmaceuticals Inc. | — | $3.85-2.41% | 89.5Bullish | +3.7% | $38.09K | Repeat | Nov 5, 2026 | $233.11M | Pharmaceutical Preparations | — | 0.18% of companyup from 0.16% in 90 days | — | |
| 13 |  VRXAVeraxa Biotech AG - Post de-SPAC | — | $1.09-5.22% | 94.7Bullish | -12.9% | $125.33K | CEO BuyClusterRepeat | Oct 28, 2026 | $154.13M | Pharmaceutical Preparations | — | 4.1% of companyup from 4.0% in 90 days | — | |
| 14 |  ANIXAnixa Biosciences Inc | — | $2.60-3.17% | 95.0Bullish | -2.9% | $291.59K | CEO BuyClusterRepeat | Oct 30, 2026 | $90.21M | Pharmaceutical Preparations | — | 5.5% of companyup from 5.3% in 90 days | — | |
| 15 |  PMNProMIS Neurosciences Inc. | — | $3.10-10.92% | 92.0Bullish | -2.3% | $134.75K | ClusterRepeat | Nov 4, 2026 | $27.80M | Pharmaceutical Preparations | — | 0.61% of companyup from 0.19% in 90 days | — | |
| 16 |  CTSOCytosorbents Corp | — | $4.90-8.73% | 89.7Bullish | -11.1% | $120.43K | CEO BuyClusterRepeat | Sep 15, 2026 | $15.44M | Surgical & Medical Instruments & Apparatus | — | 0.24% of companyup from 0.00% in 90 days | — | |
| 17 |  PHIOPhio Pharmaceuticals Corp. | — | $0.81-0.71% | 88.3Bullish | -14.6% | $104.81K | CEO BuyClusterRepeat | Nov 11, 2026 | $9.63M | Pharmaceutical Preparations | — | 8.1% of companyup from 7.1% in 90 days | — |
About the Biotech Stocks List
Every name on this list is cross-referenced against real SEC Form 4 filings and scored with our four-factor Insider Score: purchase volume, cluster effect, role weighting, and holding-change magnitude. The result is a ranked feed of where corporate insiders are actually putting their own capital — not where Wall Street says they should.
How to use this list
Hit the Filters button above the table to screen by market-cap band, sector, price, or daily move; or click any column header to sort. Use the Signals chips on each row to see at a glance which stocks have CEO buys, cluster buying, outsized purchases, or repeat buyers.
Pair this list with our live Insider Score rankings and the market heatmap to see how insider buying activity is intersecting with broader market performance.
Where the data comes from
All transactions are pulled directly from SEC EDGAR Form 4 filings and refreshed multiple times per day. Live price, volume, and average volume are sourced from real-time market quote feeds. The Insider Score is recomputed on every new filing — so the ordering you see reflects the current state of insider conviction across the list.
View the Top 5 Insider Score Picks